Raia Drogasil S.A.

RADL3

BRRADLACNOR0

Drug Retailers

Delayed Sao Paulo Other stock markets 09:48:59 2024-04-26 am EDT			5-day change	1st Jan Change
25.24 ^BRL	+1.16%		-0.94%	-14.25%

Mar. 06	Transcript : Raia Drogasil S.A., Q4 2023 Earnings Call, Mar 06, 2024
Mar. 05	Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tranche Update on Raia Drogasil S.A.'s Equity Buyback Plan announced on November 9, 2021.

November 09, 2021 at 05:18 pm EST

From August 10, 2021 to September 30, 2021, the company has repurchased 3,000,000 shares, representing 0.18% for BRL 73.23 million. With this, the company has completed the repurchase of 3,000,000 shares, representing 0.18% for BRL 73.23 million under the buyback announced on November 9, 2021.

Latest news about Raia Drogasil S.A.

Transcript : Raia Drogasil S.A., Q4 2023 Earnings Call, Mar 06, 2024	Mar. 06
Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 04	CI
Raia Drogasil S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 04	CI
Transcript : Raia Drogasil S.A., Q3 2023 Earnings Call, Nov 01, 2023	Nov. 01
Brazil's Rd Reports Q3 Adjusted EBITDA Of 658.1 Million Reais	23-10-31	RE
Raia Drogasil S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-30	CI
Transcript : Raia Drogasil S.A., Q2 2023 Earnings Call, Aug 09, 2023	23-08-09
Raia Drogasil S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Transcript : Raia Drogasil S.A., Q1 2023 Earnings Call, May 03, 2023	23-05-03
Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-01	CI
Transcript : Raia Drogasil S.A., Q4 2022 Earnings Call, Mar 08, 2023	23-03-08
Brazil's RD posts 47% increase in Q4 adjusted net profit	23-03-07	RE
Raia Drogasil S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-06	CI
Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-06	CI
Transcript : Raia Drogasil S.A., Q3 2022 Earnings Call, Nov 01, 2022	22-11-01
Raia Drogasil S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-30	CI
Transcript : Raia Drogasil S.A., Q2 2022 Earnings Call, Aug 01, 2022	22-08-01
Raia Drogasil S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-29	CI
Brazil's Raia Drogasil posts 48% increase in Q2 adjusted net profit	22-07-29	RE
Transcript : Raia Drogasil S.A., Q1 2022 Earnings Call, May 04, 2022	22-05-04
Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-02	CI
Raia Drogasil S.A.(BOVESPA:RADL3) added to Brazil IBRX 50 Index	22-05-02	CI
Transcript : Raia Drogasil S.A., Q4 2021 Earnings Call, Feb 23, 2022	22-02-23
Brazil's Raia Drogasil posts Q4 net profit of 187 mln reais	22-02-22	RE
Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-21	CI

Chart Raia Drogasil S.A.

Duration

Period

More charts

Company Profile

Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows: - branded pharmaceuticals (42%); - pharmaceutical additives (25.1%) ; - OTC products (21.3%); - generic pharmaceutical products (11.4%). At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.

Sector

Drug Retailers

Calendar

2024-05-06 - Q1 2024 Earnings Release

Related indices

BRAZIL IBOVESPA

More about the company

Income Statement Evolution

More financial data

Ratings for Raia Drogasil S.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

24.95 BRL

Average target price

31.01 BRL

Spread / Average Target

+24.28%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs without Grocery

	1st Jan change	Capi.
RAIA DROGASIL S.A.	-14.25%	8.28B
AIN HOLDINGS INC.	+32.95%	1.34B
QOL HOLDINGS CO., LTD.	+6.76%	427M
NIHON CHOUZAI CO.,LTD.	+5.93%	289M
SALUS, LJUBLJANA, D. D.	+10.56%	225M
GREEN CROSS HEALTH LIMITED	-10.09%	83.49M
MEDICAL IKKOU GROUP CO.,LTD.	+20.94%	59.81M

Retail - Drugs without Grocery

Raia Drogasil S.A.

Equities

RADL3

BRRADLACNOR0

Drug Retailers

Tranche Update on Raia Drogasil S.A.'s Equity Buyback Plan announced on November 9, 2021.

EPS Revisions